It is disclosed a method for the treatment of neurodegenerative disorders, such as ALS, Alzheimer's disease, Parkinson's disease, Huntington's disease and/or retinitis pigmentosa, which method comprises administering to a patient tauroursodeoxycholic acid or a pharmaceutically acceptable salt thereof.